Citation Impact
Citing Papers
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
After Cystectomy, Is It Justified to Perform a Bladder Replacement for Patients with Lymph Node Positive Bladder Cancer?
2002
TGF-β and cancer
1999
Optimal Management of the T1G3 Bladder Cancer
2005
Apoptosis. Its significance in cancer and cancer Therapy
1994 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
ENDOPYELOTOMY FOR PRIMARY URETEROPELVIC JUNCTION OBSTRUCTION: RISK FACTORS DETERMINE THE SUCCESS RATE
1998
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Metabolic and functional consequences of urinary reconstruction with bowel
2003
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Human prostate cancer risk factors
2004
Mesenchymal Factor Bone Morphogenetic Protein 4 Restricts Ductal Budding and Branching Morphogenesis in the Developing Prostate
2001
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
2008 Standout
Genetic predisposition and mesenchymal‐epithelial interactions in ras + myc—induced carcinogenesis in reconstituted mouse prostate
1993
A three‐centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial results
2004
Epidemiology of Prostate Cancer
2019 Standout
Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system
2001
T1G3 Bladder Tumours: The Case for Conservative Treatment
2003
The development of androgen-independent prostate cancer
2001 Standout
Flavonoids: A versatile source of anticancer drugs
2011 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Perioperative antibiotics in radical cystectomy with ileal conduit urinary diversion: Efficacy and risk of antimicrobial prophylaxis on the operation day alone
2008
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Regulation of prostatic growth and function by peptide growth factors
1996
EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in Situ
2005
Bladder cancer
2016 Standout
Cadmium Induces c-myc, p53, and c-jun Expression in Normal Human Prostate Epithelial Cells as a Prelude to Apoptosis
2000
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Identification of differentially expressed genes in organ‐confined prostate cancer by gene expression array
2001
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Gene expression correlates of clinical prostate cancer behavior
2002 Standout
Molecular and cellular mechanisms of cadmium carcinogenesis
2003 Standout
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro
2005
Active cell death in hormone-dependent tissues
1992
ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation
1992
The BMP Family Member Gdf7 Is Required for Seminal Vesicle Growth, Branching Morphogenesis, and Cytodifferentiation
2001
A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors
1996 Standout
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
The optimum timing of radical cystectomy for patients with recurrent high‐risk superficial bladder tumour
2004
Matrix metalloproteinases and tumor metastasis
2006 Standout
Clinical Experience with the N-shaped Ileal Neobladder: Assessment of Complications, Voiding Patterns, and Quality of Life in Our Series of 58 Patients
2005
Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
1993
Growth factor involvement in progression of prostate cancer
1998
FUNCTIONAL RESULTS OF ORTHOTOPIC ILEAL NEOBLADDER WITH SEROUS-LINED EXTRAMURAL URETERAL REIMPLANTATION: EXPERIENCE WITH 450 PATIENTS
2001
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Intravesical Versus Intravesical Plus Intradermal Bacillus Calmette-Guerin: A Prospective Randomized Study In Patient With Recurrent Superficial Bladder Tumors
1996
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
2010 Standout
Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells
2004
Neonatal Estrogen Exposure Up-Regulates Estrogen Receptor Expression in the Developing and Adult Rat Prostate Lobes*
1997
Orthotopic Lower Urinary Tract Reconstruction in Women Using the Kock Ileal Neobladder: Updated Experience in 34 Patients
1997
Bladder Cancer
2020 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Growth factor involvement in progression of prostate cancer.
1998
Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
2001
Induction of prostatic morphology and secretion in urothelium by seminal vesicle mesenchyme
1995
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological Malignancy
1995
Mechanisms of Estrogen Action
2001 Standout
The Kock Ileal Neobladder: Updated Experience in 295 Male Patients
1996
Defining Bacillus Calmette-Guerin Refractory Superficial Bladder Tumors
2003
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
2000 Standout
Prostate cancer in a transgenic mouse.
1995 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Neonatal Estrogen Exposure Alters the Transforming Growth Factor-β Signaling System in the Developing Rat Prostate and Blocks the Transient p21cip1/waf1 Expression Associated with Epithelial Differentiation*
1999
Complications of the Afferent Antireflux Valve Mechanism in the Kock Ileal Reservoir
1996
Roles of Hoxa1 and Hoxa2 in patterning the early hindbrain of the mouse
2000 StandoutNobel
Risk of Fracture After Radical Cystectomy and Urinary Diversion for Bladder Cancer
2014
Controls of Hair Follicle Cycling
2001 Standout
Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.
1998
BCG immunotherapy for superficial bladder cancer
2001
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
1999 StandoutNobel
Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
1993
Grade Progression and Regression in Recurrent Urothelial Cancer
2003
THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER
2000
Transforming growth factor β and cancer
1995
Works of V. Merz being referenced
No Evidence of Osteopenia 5 to 8 Years After Ileal Orthotopic Bladder Substitution
1996
Differential expression of transforming growth factor-?1 and ?3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer
1994
Analysis of early failures after intravesical instillation therapy with bacille Calmette‐Guerin for carcinoma in situ of the bladder
1995
Transforming growth factor-β3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma
1997
Elevated Transforming Growth Factor-β 1 and β3 mRNA Levels are Associated withras+myc-induced Carcinomas in Reconstituted Mouse Prostate: Evidence for a Paracrine Role during Progression
1991
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.
1994
Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations
1997
Endopyelotomie bei primärer Ureterabgangsstenose: Bedeutung der Nierenbeckenkelchsystemgröße
1995
Experimental oncogene induced prostate cancer.
1991
Experience in 100 Patients with an Ileal Low Pressure Bladder Substitute Combined with an Afferent Tubular Isoperistaltic Segment
1995
No Evidence of Osteopenia 5 to 8 Years After Ileal Orthotopic Bladder Substitution
1996